Saul Centers (BFS) director adds 2,000 shares through stock award
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Saul Centers, Inc. director George Patrick Clancy Jr reported a compensation-related share award rather than a market trade. He received 2,000 shares of Common Stock at a price of $0.0000 per share, classified as a grant or award.
These are restricted shares that vest in three equal annual installments on the first three anniversaries of May 8, 2026, assuming continued service. After this award, Clancy directly holds 22,605 Common Stock shares. He also holds phantom stock units linked to 4,452.024 Common shares under the directors’ deferred compensation plan and several director stock options covering 2,500 underlying shares each at exercise prices between $33.79 and $59.41 with expirations from 2027 to 2033.
Positive
- None.
Negative
- None.
Insider Trade Summary
9 transactions reported
Mixed
9 txns
Insider
CLANCY GEORGE PATRICK JR
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 2,000 | $0.00 | -- |
| holding | Director Stock Option | -- | -- | -- |
| holding | Director Stock Option | -- | -- | -- |
| holding | Director Stock Option | -- | -- | -- |
| holding | Director Stock Option | -- | -- | -- |
| holding | Director Stock Option | -- | -- | -- |
| holding | Director Stock Option | -- | -- | -- |
| holding | Director Stock Option | -- | -- | -- |
| holding | Phantom Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 22,605 shares (Direct, null);
Director Stock Option — 2,500 shares (Direct, null);
Phantom Stock — 4,452.024 shares (Direct, null)
Footnotes (1)
- Represents restricted shares of Common Stock. Such shares vest on the first three anniversaries of May 8, 2026 in equal annual installments, assuming continued service. New phantom shares are issuable pursuant to the Issuers Deferred Compensation Plan for Directors, as amended and restated effective May 17, 2024 (the Deferred Compensation Plan), under its 2024 Stock Incentive Plan. Phantom shares issued prior to May 17, 2024, continue to be subject to the terms of the Issuers deferred compensation plan for directors in effect prior to the amendment and restatement of the Deferred Compensation Plan. The conversion of phantom shares issued on or after May 17, 2024, into shares of the Issuers common stock is governed pursuant to terms of the Issuers Deferred Compensation Plan under its 2024 Stock Plan and the reporting persons Deferred Fee Agreement. The conversion of phantom shares issued prior to May 17, 2024, into shares of the Issuers common stock is governed pursuant to the terms of the Issuers deferred compensation plan for directors in effect prior to the amendment and restatement of the Deferred Compensation Plan and the reporting persons Deferred Fee Agreement. Includes 77.495 shares awarded April 30, 2026 as dividend reinvestments on shares of phantom stock held by the reporting person pursuant to the Deferred Compensation Plan.
Key Figures
Restricted share grant: 2,000 shares
Direct common holdings: 22,605 shares
Phantom stock underlying shares: 4,452.024 shares
+4 more
7 metrics
Restricted share grant
2,000 shares
Common Stock award on May 8, 2026 at $0.0000 per share
Direct common holdings
22,605 shares
Total Common Stock directly owned after the grant
Phantom stock underlying shares
4,452.024 shares
Underlying Common Stock for phantom stock units
Dividend reinvestment phantom shares
77.495 shares
Awarded April 30, 2026 as dividend reinvestments
Director options block size
2,500 shares each
Underlying Common Stock per Director Stock Option grant
Option exercise prices
$33.79–$59.41
Range of Director Stock Option exercise prices
Option expirations
2027–2033
Director Stock Option expiration dates
Key Terms
Phantom Stock, Deferred Compensation Plan for Directors, Director Stock Option, restricted shares, +1 more
5 terms
Phantom Stock financial
"Represents phantom stock units linked to 4,452.024 underlying Common shares."
A phantom stock is a form of compensation that gives employees or executives the benefits of stock ownership, such as the increase in stock value, without actually giving them real shares. It acts like a promise to pay the employee the equivalent value of company stock later, often as a bonus or incentive. This allows companies to motivate and reward staff without diluting ownership or transferring actual shares.
Deferred Compensation Plan for Directors financial
"New phantom shares are issuable pursuant to the Issuers Deferred Compensation Plan for Directors."
A deferred compensation plan for directors is an arrangement that lets board members postpone receiving part of their pay until a later date—often retirement or a set future time—so the money can grow or be paid under specified conditions. Think of it like directing a portion of your paycheck into a locked savings account that pays out later; investors care because it creates future cash or stock obligations, signals how the company motivates and retains leadership, and can affect shareholder value through timing of payouts or potential dilution.
Director Stock Option financial
"Director Stock Option grants cover 2,500 underlying Common Stock shares each."
Deferred Fee Agreement financial
"Conversion of phantom shares is governed by the Deferred Compensation Plan and the reporting persons Deferred Fee Agreement."
FAQ
What does the latest Form 4 for Saul Centers (BFS) show?
The Form 4 reports a share award to director George Patrick Clancy Jr, granting 2,000 restricted Common Stock shares. This is a compensation-related acquisition, not an open-market trade, and increases his directly held common shares to 22,605.
What phantom stock holdings are reported for the Saul Centers (BFS) director?
The filing shows phantom stock linked to 4,452.024 underlying Common shares under the Deferred Compensation Plan for Directors. These include 77.495 shares added on April 30, 2026 as dividend reinvestments on existing phantom stock units.
What director stock options does the Saul Centers (BFS) director still hold?
The director holds several Director Stock Options, each covering 2,500 underlying Common shares, with exercise prices from $33.79 to $59.41. These options have expiration dates between 2027 and 2033, indicating a long-dated equity incentive position.